featured
Colorado Lawmakers Approve Bill To Let Governor Grant Mass Pardons For Psychedelics-Related Convictions

Published
5 months agoon

Colorado lawmakers have advanced a bill that would empower the governor to grant pardons to people who’ve been convicted of psychedelics-related offenses, while also revising implementation rules for the state’s voter-passed psychedelics legalization law.
About a week after Sen. Matt Ball (D) and Rep. Lisa Feret (D) filed the legislation, SB25-297, it cleared the Senate Health & Human Services Committee in a 7–2 vote on Wednesday after members adopted a minor amendment.
If enacted, the measure would authorize Gov. Jared Polis (D) or future governors to grant clemency to people with convictions for low-level possession of substances such as psilocybin, ibogaine and DMT that have since been legalized for adults under state law.
In 2023, Polis called on lawmakers to take steps allowing him to issue mass pardons for people with prior psychedelics convictions as the voter-approved legalization policy was being implemented.
The governor said at the time that he needed the legislature to act to provide him with pardon authority, “so anybody who has something on their criminal record that is now legal can have that expunged and doesn’t hold them back from future employment opportunities.”
Ball said at Wednesday’s hearing on the bill that the retroactive pardons would affect “a very small group of people” in the state, likely fewer than 20. But he noted that clemency language was included in the voter-passed ballot measure, Prop. 122, that legalized the state’s so-called natural medicine program.
“This gives the governor the authority to enact the will of the people as enacted in Proposition 122,” he said.
In addition to granting the governor that authority, the committee-passed measure would also require the Colorado Department of Public Health and Environment (CDPHE), Department of Revenue (DOR) and Department of Regulatory Agencies (DORA) to “collect information and data related to the use of natural medicine and natural medicine products.”
That would include data on law enforcement activities, adverse health events, consumer protection claims and behavioral impacts related to psychedelics.
“Subject to available appropriations, CDPHE shall also collect relevant data and information related to the use of natural medicine from facilitators and healing centers,” the bill says. “CDPHE is required to create and maintain a database of the information collected.”
The legislation would further amend rules around licensing and ownership of psychedelic healing centers. For example, it removes a requirement for fingerprint background checks for owners and employees of licensed facilities, making it so they would only be subject to a name-based criminal background check.
It additionally “requires the state licensing authority to adopt rules related to product labels for regulated natural medicine and regulated natural medicine products and permits the state licensing authority to adopt rules regarding the types of regulated natural medicine products that can be manufactured.”
An amendment from Ball adopted before Wednesday’s committee vote made adjustments to the proposals conflicts of interest section, clarifying that funding for the program—which would be made up of gifts, grants and donations from third parties—not come from parties with a direct financial interest in the natural medicine program or those that can improperly influence data collection.
The proposal overall has support from an array of advocates, including psychedelic medicine proponents as well as groups more skeptical of legalization. Public commenters seemed to agree that the bill’s data collection provisions would help observers both inside and outside Colorado better understand the outcomes around regulated psychedelics.
“Colorado is at the forefront of psychedelic policy. Other states are watching us closely,” said Joshua Kappel, a co-founding partner at the law firm Vicente LLP and one of the drafters of Prop. 122, who read from a letter from five Colorado-based psychiatrists. “If we want to lead with integrity and responsibility, we must demonstrate that a regulated psychedelic program can be not only innovative, but accountable and effective.”
“The data we collect here will shape national conversations, inform legislation, further guide scientific research and treatment protocol development and, most importantly, help save lives,” the letter said.
Rachel O’Bryan, co-founder and strategic projects director at the group One Chance to Grow Up, which aims to protect kids from risks associated with marijuana and THC, told lawmakers the organization’s members and advisory council support the bill.
“One Chance believes best policy is informed by evidence and not opinions or assumptions,” O’Bryan said, “and that requires the collection of data. This bill would improve the collection and dissemination of data regarding the impact of Colorado’s natural medicine code on Colorado citizens and institutions.”
“Colorado is a leader in the data collection for marijuana impacts,” she added, “and this bill would ensure that Colorado is a leader in the data collection for natural medicine impacts.”
Andrea Stojsavljevic, a senior policy coordinator at Children’s Hospital Colorado, also urged lawmakers to support the bill.
“These types of data collection can be critically informative to guide future policymaking,” Stojsavljevic said. If data show increasing youth use, diversion of products or accidental ingestion, for example, “then we can return to the legislature to assess additional protections to avoid potentially serious health risks and children and youth.”
Members of the committee spent minimal time discussing the bill before the vote, though some questions came from Republican Sens. Scott Bright—who ultimately voted in favor of the measure—and Lisa Frizell, who cast her vote against it.
Bright asked for more details about the changes to data collection and also asked for an update on revenue from psychedelics licensing, which he said “a couple years ago” was projected to be “north of $1 million.”
Allison Robinette, director of policy and regulatory affairs at the state Department of Revenue’s marijuana and natural medicines divisions, said officials are “still working through the process” but “believe we’re on track for our projections.”
“I believe we’re on track, but, you know, we’re so early in the process that there’s a lot to play out and to be seen here,” she said.
Frizell’s questions centered on whether the bill would allow publicly funded institutions, such as universities, to make gifts, grants or donations—a move she said would sidestep how funding decisions are supposed to be made.
“It’s not OK to get around our budgetary issues by passing the funding off to publicly funded institutions, whether it is an academic institution or some other organization,” she said after asking a number of related questions to witnesses. “So I think that that’s a problem. And if you can’t explain that, then that’s a bigger problem.”
Sponsor Ball, for his part, acknowledged that his office hadn’t considered public universities as possible funders when drafting the bill.
“Most of the discussions we’ve had have all been around national nonprofits,” he said, listing a handful of organizations. “I know there’s more, but there’s a number of groups who are interested in this type of research, who see an opportunity in Colorado because we have the ability to collect aggregate data due to what we’re rolling out.”
Besides Frizell, the only other no vote on SB25-297 was from Sen. Lisa Cutter (D). The bill next proceeds to the Senate Appropriations Committee.
Meanwhile in Colorado, earlier this month the governor signed into law a bill that would allow a form of psilocybin to be prescribed as a medication if the federal government authorizes its use.
While Colorado already legalized psilocybin and several other psychedelics for adults 21 and older through the voter-approved ballot initiative, the newly enacted reform will make it so drugs containing an isolated crystalized version synthesized from psilocybin can become available under physician prescription.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
As of January, meanwhile, Colorado regulars have been authorized to approve licenses for psilocybin service centers where adults can access the psychedelic in controlled settings.
The governor signed a bill to create the regulatory framework for legal psychedelics in 2023.
But lawmakers evidently are interested in setting the state up to allow for a more conventional system of distribution for certain psychedelics. In 2022, Polis also signed a bill to align state statute to legalize MDMA prescriptions if and when the federal government ultimately permits such use.
Whether FDA moves forward with any such approvals in uncertain, and the agency faced criticism last year after rejecting an application to allow MDMA-assisted therapy for people with PTSD.
Meanwhile in Colorado, a bill that would have limited THC in marijuana and outlawed a variety of psilocybin products will no longer move forward this session following the lead sponsor’s move to withdraw the bill.
Photo courtesy of Dick Culbert.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
8,000 cannabis plants seized from illegal Bradford grow-op
-
New York Lawmakers Schedule Psychedelics-Focused Hearing To Discuss ‘Medicinal Value And Risks’ Of Psilocybin
-
Curaleaf Opens Cannabis Dispensaries in Florida, Ohio
-
How to Protect Your Outdoor Cannabis Crops From Pests
-
Feds provide anti-cannabis group a platform to bash legalization (Newsletter: September 15, 2025)
-
Dozen arrested after south Mississippi bust for illegal sales to underage customers
featured
New York Lawmakers Schedule Psychedelics-Focused Hearing To Discuss ‘Medicinal Value And Risks’ Of Psilocybin

Published
50 minutes agoon
September 15, 2025
New York lawmakers have scheduled a hearing to discuss the medical potential of psilocybin as the state considers pursuing a pathway for regulated access to the main psychedelic component of “magic mushrooms.”
In a notice published by the Assembly Health Committee on Wednesday, Chairwoman Amy Paulin (D) noted that, while psilocybin is currently listed as a Schedule I drug, the federal Food and Drug Administration (FDA) has designated it as a “breakthrough therapy” for major depression—indicating that “the therapy may offer improved results for such conditions over currently approved treatments.”
A meeting to go over the science and potential regulations of the novel therapy is scheduled for September 30. Oral testimony is by invite only from the committee, and witnesses have not yet been announced.
“Various localities have enacted measures regarding psilocybin, including the states of Colorado, Oregon, and New Mexico which allow for its supervised use, citing its potential as a treatment for some mental health conditions,” the notice says. “However, more information is needed to better understand the medicinal value that psilocybin may have as a therapy in New York State.”
“To this end, the Committee seeks to hear from researchers, medical experts, and other stakeholders on the potential medicinal value and risks of psilocybin,” Paulin said.
The chairwoman introduced a bill to legalize psilocybin for adults last year, provided they obtain a permit after undergoing a health screening and educational course.
New York legislators have taken special interest in psychedelics reform in recent sessions.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
For example, in January, Assemblymember Linda Rosenthal (D) filed legislation calling for the legalization of certain entheogenic substances such as psilocybin and ibogaine for adults 21 and older.
The bill would amend state statute to make legal the “possession, use, cultivation, production, creation, analysis, gifting, exchange, or sharing by or between natural persons of twenty-one years of age or older of a natural plant or fungus-based hallucinogen.”
DMT, ibogaine, mescaline, psilocybin and psilocyn would fall under the definition of “natural plant or fungus-based hallucinogens” that would be legalized by the bill.
Rosenthal’s measure was introduced just days after another New York lawmaker, Sen. Nathalia Fernandez (D), prefiled a measure that would legalize psilocybin therapy for patients with qualifying conditions.
Under that proposal, people could receive psilocybin treatment from a certified facilitator in a clinical setting, or at their home if they’re unable to travel. Patients and facilitators would receive protections against state-level prosecution.
Fernandez also filed an earlier version of the bill last session, but it did not move out of committee either. Only minor technical changes have been made in the latest iteration.
Bicameral New York lawmakers said at a briefing last year that there was a “real chance” that legislation to legalize psilocybin-assisted therapy would advance through committee, emphasizing that delaying action would “neglect” many “people who need help” with certain mental health conditions. That did not ultimately materialize, however.
“We’re in a mental health crisis, and so we need every tool that’s available to us,” Assemblymember Pat Burke (D), who sponsored another bill to create a psilocybin therapy pilot program for 10,000 people, said. He added that “we’re here to turn the page” on the broader drug war.
Photo courtesy of Dick Culbert.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Curaleaf Opens Cannabis Dispensaries in Florida, Ohio

Published
2 hours agoon
September 15, 2025
[PRESS RELEASE] – STAMFORD, Conn., Sept. 15, 2025 – Curaleaf Holdings Inc., a leading international provider of consumer cannabis products, announced the opening of two new dispensaries: Curaleaf Apopka, located at 1809 E. Semoran Blvd., Apopka, Fla., 32703, and Curaleaf Girard, located at 801 N State St., Girard, Ohio, 44420. With these dual openings, Curaleaf expands to 69 retail locations in Florida, five in Ohio and 157 nationwide.
Curaleaf Apopka strengthens the company’s presence in Central Florida, providing convenient access for registered medical cannabis patients across the Greater Orlando region. Curaleaf Apopka offers a wide portfolio of medical cannabis products, including Curaleaf’s Select brand vapes and edibles, Florida-exclusive Reef flower, Grassroots Dark Heart Collection flower, Anthem pre-rolls, Miss Grass pre-rolls and more. To ensure patient satisfaction, Curaleaf Florida is offering a 72-hour Flower Satisfaction Guarantee on select premium eighths from Grassroots and Reef. The store will operate from 9:00 a.m. to 8:30 p.m. Monday through Saturday and 10 a.m. to 6 p.m. on Sundays.
Meanwhile, Curaleaf Girard marks the company’s first dispensary within the city of Girard, and enhances access for both medical patients and adult-use consumers across Ohio’s Northeast region. The store features a selection including Select BRIQ all-in-one vapes, Grassroots Dark Heart Collection flower, Grassroots pre-rolls, JAMS and Select XBites edibles and Find flower. Curaleaf will be introducing Grassroots and Find pre-rolls in Singles and 5-pack Shorties, as state regulations now allow for the sale of pre-rolls. Curaleaf Girard will be open 9 a.m. to 8 p.m. Monday through Saturday and 9 a.m. to 7 p.m. on Sundays.
“Each new store opening reflects our mission to expand safe, convenient access to high-quality cannabis across the country,” Curaleaf Chairman and CEO Boris Jordan said. “With Apopka, we are deepening our roots in Florida by serving an important new region for medical patients, and with Girard, we are proudly delivering the first licensed dispensary to the city. Together, these milestones show our commitment to patients and consumers who rely on cannabis for their well-being, while reinforcing Curaleaf’s leadership in both established and emerging markets.”
Local celebrations will mark the openings:
- Curaleaf Apopka will host a grand opening on Sept. 19, 2025, from noon to 5 p.m., featuring special promotions, giveaways and an interactive “Live Lounge” livestream with Curaleaf cultivation leaders.
- Curaleaf Girard will celebrate its opening with a ribbon-cutting ceremony alongside the Girard Chamber of Commerce at a later date, featuring exclusive promotions and complimentary refreshments.
For more information on Curaleaf’s dispensaries, products and patient resources, visit www.curaleaf.com.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
How to Protect Your Outdoor Cannabis Crops From Pests

Published
3 hours agoon
September 15, 2025
Mason Walker is stressed out. With the already intense pressures of running his cannabis farm in Oregon, he’s facing another challenge this season: more aphids threatening to chew up his plants at East Fork Cultivars.
“This year, I’d say we’re facing a problem with 50 percent more aphids than last year,” he says, “and the conditions this summer in Southern Oregon have let them thrive even more.”
Shawn Honaker can relate, but his anxiety stems from the bustling activity of a different kind of pest: grasshoppers. The manager of Yeti Farms in Pueblo, Colo., says his 55-acre outdoor farm is often a buffet for grasshoppers, and he says this year is the worst he has seen them propagate.
“Before our mitigation efforts, if you walked into any area of my farm, within 10 feet you would scare up to 500 grasshoppers,” Honaker says, adding that his farm’s arid region leaves little greenery for grasshoppers to enjoy, making his cannabis plants a prime target for a feast. Grasshoppers also hop his fence with their impressive flying ability. To make matters more challenging, a single insect can lay hundreds of eggs, depending on the species.
As cannabis and hemp farmers across the U.S. confront surging pest management challenges, experts in the sector shared with Cannabis Business Times several approaches to stem the tide of those pesky bugs and the serious damage they can do to cannabis and hemp crops.
From aphids to spider mites to grasshoppers to whiteflies, these pests aren’t going anywhere any time soon, but cannabis companies can be proactive to ensure their plants stay healthy.Mason Walker of East Fork CultivarsPhoto courtesy East Fork Cultivars
The Benefits of Going Biological
Walker isn’t sitting on his hands this fall, and he’ll follow through on what he experimented with during the chaotic aphid season last year. His farm worked with Oregon State University to raise its own parasitic wasps and released them into the fields to push away the aphid storm. “This was seemingly effective at limiting aphid activity and damage, and we’ll do the same this year,” Walker says.
Honaker is battling his pest trouble with a similar approach. For the past few years, he’s introduced guinea fowl onto his field to help them drive out not just insects but also rodents and snakes.
Raymond Cloyd, a professor of entomology at Kansas State University, applauds what Walker and Honaker are doing to combat their pest problems. “When you’ve got a crop that’s going to be inhaled or used commercially, … biocontrol is a great option,” he says.
When Cloyd consults with cannabis companies to help them with their insect infiltrations, he suggests battling mites with other mites. “With one company, we introduced predatory mites to fight off mites, and that proactive solution proved to be very successful,” he recalls.
There are also types of predatory mites that can stave off thrips, whiteflies and aphids, he adds.A view of Yeti Farms in Pueblo, Colo., where grasshoppers are an increasing threat to plants.Photo courtesy Yeti Farms
Monitoring and Sanitation Are Crucial
Taking an anticipatory approach to pest management also requires careful monitoring of your plants, whether hemp or cannabis, Cloyd says.
Growers can use visual monitoring methods such as placing sticky yellow cards above the crop canopy, which can commonly catch whiteflies and similar bugs.
But don’t forget the beat method, he advises. Growers should place a white piece of paper attached to a clipboard under their plants and then shake the stem and let the bugs fall on the paper. Mites, thrips and aphids are commonly found with this method, he says.
“This approach has to be done at least once or twice a week because you need to detect those populations early in order to spread out your biological control agents,” Cloyd says.
What About Hemp?
Cultivators of all species of Cannabis sativa L. face pressures to keep their plants insect-free, including hemp growers, says Marguerite Bolt, the hemp extension specialist at Purdue University.
The challenges, however, can vary by region, Bolt says. In western states, for example, the beet leaf hopper is an increasingly problematic pest due to how it’s the vector of the beet curly top virus. Industrial hemp growers in some dry, western states are experiencing grasshoppers chewing up plants at a high rate. In the Great Lakes region, growers see caterpillar pests, including corn earworm and yellow-striped armyworm, which feed on the female flowers and in the grain heads.
Monitoring hemp plants is also integral for hemp growers, Bolt explains. “I recommend growers spend time with their plants throughout the season and make notes on what damage is occurring and when,” she says. “Certain pests are going to be difficult to manage, so strategies like altering planting or harvest dates, selecting tolerant and resistant cultivars, sanitation practices, and the use of registered pesticides may be necessary.”
Learning as much as you can about the pests that are increasingly invading your crops can also help, Bolt says. She adds, “Some pests, especially foliar feeding beetles, cause some ugly damage, but if plants are larger, they can withstand a lot.”Yeti Farms’ Shawn Honaker uses a propane-fired weed burner, resembling a Bush Hog mower, attached to the back of a pickup truck, he says, “but instead of blades, we use propane flames that penetrate the soil and destroy as many grasshopper eggs as we can.”Photo courtesy Yeti Farms
Cloyd highlights an issue for hybrid growers who manage both hemp and other commercial crops. “For outdoor hemp growers that have hemp close to corn or soybean fields, during harvest the hemp will be more susceptible to insects moving in, such as the corn earworm.” (The corn earworm is a common pest of corn, as well as tomatoes and several other crops, according to Purdue University’s Entomology Extension.) “That’s why you have to get proactive,” says Cloyd.
For a more extreme solution to stave off invasive pests, growers can fight fire with … well, fire. Honaker uses a propane-fired weed burner, resembling a Bush Hog mower, attached to the back of a pickup truck, “but instead of blades,” he says, “we use propane flames that penetrate the soil and destroy as many grasshopper eggs as we can. That’s what we call our organic weed killer.”
David Silverberg is a freelance journalist who writes about cannabis and the cannabis industry.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

8,000 cannabis plants seized from illegal Bradford grow-op

New York Lawmakers Schedule Psychedelics-Focused Hearing To Discuss ‘Medicinal Value And Risks’ Of Psilocybin

Curaleaf Opens Cannabis Dispensaries in Florida, Ohio

How to Protect Your Outdoor Cannabis Crops From Pests

Feds provide anti-cannabis group a platform to bash legalization (Newsletter: September 15, 2025)

Dozen arrested after south Mississippi bust for illegal sales to underage customers

The Toking Traveler: Why Amsterdam Weed Is Mostly Boof

Arkansas Medical Marijuana Sales Are On Track To Set A New Annual Record

When Cannabis Brands Blur Into Youth Culture, Regulators Notice: Lessons From Tobacco’s Past

Rhode Island Marijuana Dispensary License Application Process Officially Launches

Middle school student found with cannabis in bookbag, Charles County deputies say

Smugglers who brought drugs on an industrial scale into Wales jailed

Attorney pulls out bag of cannabis in NC Supreme Court hearing

WHO AM I? Man wanted for New Bern cannabis store theft

Cannabis packages under scrutiny

California authorities shut down nearly $30 million worth of illegal cannabis operations

A Green Light for Cannabis? Europe Waits While the U.S. Untangles the Red Tape

Move Over, Booze: Weed Drinks Pulled $1.1 Billion in U.S. Sales in 2024

Congressional Committee Votes To Repeal Marijuana Expungements Law In Washington, D.C.

Times Square Welcomed Its Brightest Cannabis Billboard Yet

Smoking Marijuana With A Water Bong Doesn’t Effectively Filter Compounds From Smoke, Study Suggests

A Beginner’s Guide for Watering Cannabis Plants

Massachusetts Lawmakers Approve Bill To Create Psychedelic Therapy Pilot Program

From the Dark Web to the Streets: Meet the Canadian Distributing Pure Cocaine to Save Lives

Alert: Department of Cannabis Control updates data dashboards with full data for 2023

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

5 best CBD creams of 2024 by Leafly

EU initiative begins bid to open access to psychedelic therapies

New Study Analyzes the Effects of THCV, CBD on Weight Loss

Free delta-9 gummies from Bay Smokes

5 best autoflower seed banks of 2024 by Leafly

Discover New York’s dankest cannabis brands [September 2024]

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

May 2024 Leafly HighLight: Pink Runtz strain

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

Recreational cannabis on ballot for third time in South Dakota

5 best THC drinks of 2024 by Leafly

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Mississippi city official pleads guilty to selling fake CBD products

6 best CBD gummies of 2024 by Leafly

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

The Daily Hit: October 2, 2024

5 best delta-9 THC gummies of 2024 by Leafly

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

5 best THCA flower of 2024 by Leafly

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows
Trending
-
California Cannabis Updates1 year ago
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year ago
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list1 year ago
5 best CBD creams of 2024 by Leafly
-
Business12 months ago
EU initiative begins bid to open access to psychedelic therapies
-
cbd1 year ago
New Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Bay Smokes1 year ago
Free delta-9 gummies from Bay Smokes
-
cannabis brands12 months ago
Discover New York’s dankest cannabis brands [September 2024]
-
autoflower seeds12 months ago
5 best autoflower seed banks of 2024 by Leafly